Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Private equity
Manufacturing
Lonza shakes off capsule business in $3B deal with Lone Star
Under the deal with Lone Star Funds, Lonza maintains a 40% stake in its capsules and health ingredients business.
Zoey Becker
Mar 6, 2026 4:00pm
Biopharma's rebound keeping pace so far
Jan 30, 2026 9:34am
Bavarian Nordic's board chair departs after acquisition fumble
Nov 13, 2025 4:41pm
PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT
Sep 11, 2025 10:25am
Permira eyes $4B sale of CDMO Cambrex: FT
Sep 9, 2025 10:36am
As Bavarian Nordic reports sales boost, CEO pushes for takeover
Aug 22, 2025 11:30am